Fearing that genetic testing and research could reveal information about an individual that could make them uninsurable or at risk of being fired by their employer, the Genetic Information Nondiscrimination Act, or GINA, was signed into law in May 2008.
Harvard Medical School genetics researcher Robert Green conducted a study that found people who discovered they had a gene associated with Alzheimer’s disease were five times more likely to buy long-term care insurance.
That’s dangerous to businesses who sell long-term care insurance because the pool of beneficiaries could become much riskier. GINA does not currently apply to this category of insurer, but politicians who introduced the law want to update it with more restrictions on insurers, according to the report.
More Articles on Genetic Testing:
100 Hospitals With Great Heart Programs
El Camino Hospital in California Launches High-Risk Breast Program
Hospital of Central Connecticut to Break Ground on $40M Cancer Center
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
